News

Public · Published

Needham maintains Core Scientific at Buy, lowers price target to $28 from $35

Needham kept its Buy rating on Core Scientific but reduced its price target to $28 from $35, a 20.0% decrease. The new target implies 146.0% upside from the November 5 closing price of $11.38. Four other recent analyst targets ranged from $30 to $38.

Published:

Updated:

What happened

Needham kept its Buy rating on Core Scientific but reduced its price target to $28 from $35, a 20.0% decrease. The new target implies 146.0% upside from the November 5 closing price of $11.38. Four other recent analyst targets ranged from $30 to $38.

Confirmed

Global impact / market context

The lower target signals that Needham sees less potential value than before, even while keeping its Buy rating. If investors respond by changing their holdings, Core Scientific’s share price and ability to raise funds through stock issuance could be affected; the article reports no such market response.

Analyst inference

The analyst opinions are mixed in target level: Needham’s $28 target is below the $30–$38 range of four other notes from the past 30 days. Targets are estimates, not promised prices, and the article gives no explanation for Needham’s reduction or evidence of changed company operations.

Confirmed

What to watch

  1. Watch for further analyst updates: additional target reductions or rating changes could influence investor expectations, while the article provides no reasons for Needham’s revised estimate. Analyst inference
  2. Compare future targets with the reported $30–$38 range from four recent notes; a wider gap could indicate less agreement about Core Scientific’s expected value. Analyst inference
  3. The article states that Needham maintained its Buy rating and lowered its target to $28 from $35, a 20.0% decrease. Confirmed

Evidence

  • Original source link unavailable